微创时代残胃癌与原发性上三分之一胃癌的技术表现、手术结局与肿瘤预后综合比较:三项前瞻性试验的汇总分析
本研究比较腹腔镜全胃切除术治疗残胃癌与原发性上胃癌的技术表现及短期和长期结局。倾向性评分匹配后纳入46例残胃癌和92例上胃癌患者,残胃癌组腹部粘连更重、术中技术错误和不良事件更多、术后并发症率更高(28.3% vs 7.6%,P=.001),但OSATS评分和远期肿瘤学结局相当。
要点
- 残胃癌腹腔镜全胃切除术中技术错误和术中不良事件更多,尤其是I级出血。
- 残胃癌术后并发症率显著高于上胃癌(28.3% vs 7.6%,P=.001),但严重并发症率相似。
- 两组3年无病生存、总生存和复发模式等远期肿瘤学结局相当。
核心结论
- 残胃癌与上胃癌腹腔镜全胃切除术后远期肿瘤学结局相当,但残胃癌术中错误和不良事件更多、术后并发症率更高。
研究设计与样本
- 本研究为前瞻性研究(FUGES-004),纳入2016年6月至2020年6月福建医科大学附属协和医院50例残胃癌患者。
- 采用1:2倾向性评分匹配从FUGES-001和FUGES-002研究中选取上胃癌患者,最终分析46例残胃癌和92例上胃癌。
- 技术表现采用通用错误报告工具、客观结构化技术技能评估(OSATS)和术中并发症分类评估。
主要发现
- 残胃癌组上腹部、中腹部和肠肠区域粘连更严重(P < .001)。
- 残胃癌组术中技术错误和术中不良事件更多,尤其是I级出血(P < .05)。
- 两组OSATS评分相当(30.8 vs 31.0,P = .799)。
- 残胃癌组术后并发症率显著更高(28.3% vs 7.6%,P = .001),但严重并发症率相似(P = .333)。
- 两组3年无病生存、总生存和复发模式等远期肿瘤学结局相当(log-rank P > .05)。
临床怎么用
- 对于复杂残胃癌病例,腹腔镜全胃切除术可作为有效治疗选择。
- 在高流量中心由经验丰富的外科医生操作时仍应谨慎,并实施更严格的围术期管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: To compare the technical performances and short- and long-term outcomes of laparoscopic total gastrectomy for remnant gastric cancer and primary upper gastric cancer. METHODS: This prospective study (FUGES-004 study) enrolled 50 remnant gastric cancer patients who underwent laparoscopic total gastrectomy at Fujian Medical University Union Hospital between June 2016 and June 2020 (ClinicalTrials.gov identifier: NCT02792881). Propensity score matching (1:2) was used to select upper gastric cancer patients who underwent laparoscopic total gastrectomy in the FUGES-001 and FUGES-002 studies. Technical performance was assessed using the General Error Reporting Tool, Objective Structured Assessment of Technical Skills (OSATS), and Intraoperative Complication Classification. RESULTS: After matching, 46 remnant gastric cancer and 92 upper gastric cancer patients were included in the final analysis. Abdominal adhesions in the epigastrium, central abdomen, and bowel-to-bowel regions were more severe in the remnant gastric cancer group (P < .001). The remnant gastric cancer group had more technical errors and intraoperative adverse events (especially grade I bleeding) during surgery (P < .05). However, the Objective Structured Assessment of Technical Skills scores were comparable between the remnant gastric cancer and upper gastric cancer groups (30.8 vs 31.0, P = .799). Although the severe postoperative complication rates were similar between the 2 groups (P = .333), the postoperative complication rate was significantly higher in the remnant gastric cancer group (28.3% vs 7.6%, P = .001). Additionally, the long-term oncologic outcomes (including 3-year disease-free survival, overall survival, and recurrence pattern) were comparable between the remnant gastric cancer and upper gastric cancer groups (log-rank P > .05). CONCLUSIONS: Although the long-term oncologic outcomes were comparable between the groups, the remnant gastric cancer group had more intraoperative errors and adverse events and higher postoperative complication rates than the upper gastric cancer group. For complex remnant gastric cancer cases, laparoscopic total gastrectomy may serve as an effective therapeutic option. However, experienced surgeons at high-volume centers should exercise caution when performing laparoscopic total gastrectomy and implement more rigorous perioperative management strategies.
引用
- Wu D, Zhong Q, Zhang ZQ, et al. Comprehensive comparison of technical performance, surgical outcomes, and oncologic prognosis between remnant gastric cancer and primary upper-third gastric cancer in the era of minimally invasive surgery: A pooled analysis of 3 prospective trials. Surgery. 2025. PMID: 40344992. doi:10.1016/j.surg.2025.109395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。